Short interest in ARS Pharmaceuticals Inc (NASDAQ:SPRY) increased during the last reporting period, rising from 13.68M to 14.81M. This put 28.65% of the company's publicly available shares short.

Short interest for ARS Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of ARS Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.38M shares traded per day, it would take 10.73 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.